Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2001
12/04/2001US6326489 Surface-bound, bimolecular, double-stranded DNA arrays
12/04/2001US6326487 Oligonucleotides, antisense agents, viricides and gene expression
12/04/2001US6326486 Polynucleotide probes for detection and quantitation of bacteria in the family enterobacteriaceae
12/04/2001US6326485 Oligonucleotide for use in the detection of preferential protozoan nucleotide sequences in sample
12/04/2001US6326480 Antisense reporter system for assaying RNA virus replication
12/04/2001US6326391 Inhibitors of multidrug transporters
12/04/2001US6326352 Compounds and methods for modulating cell adhesion
12/04/2001US6326351 Insecticides
12/04/2001US6326215 Molecular wire injection sensors
12/04/2001US6326207 Human sodium-dependent phosphate cotransporter
12/04/2001US6326205 Methods for use of Mpl ligands with primitive human stem cells
12/04/2001US6326204 Generating aggregations which produce preferential particles; transform cells, screen cells for preferential activity, recover cells with preferential activity
12/04/2001US6326199 Hybridization and rnace activation in a cell with oligonucleotides
12/04/2001US6326189 Nucleic acid separating vessel, a method of manufacturing the nucleic acid separating vessel, and a method for separating the nucleic acid
12/04/2001US6326182 Nucleic acid molecule encoding an arylacetamide deacetylase with nucleotide sequences
12/04/2001US6326181 Cell volume-regulated human kinase h-sgk
12/04/2001US6326180 Isolated human enzyme, nucleic acid molecules encoding human enzyme, and uses thereof
12/04/2001US6326174 Isolating catalytic nucleic acids; obtain single stranded nucleotide sequences, mix with substrate, separate single-stranded nucleotide sequences, recover catalytic single stranded nucleotide sequences
12/04/2001US6326173 Amplification of target nucleic acids; join nucleic acid to chip, hybridize to primer, incubate with enzymes, amplify, recover amplification products
12/04/2001US6326170 Prokaryotic polynucleotides, polypeptides and their uses
12/04/2001US6326165 Nucleotide sequences used for the detection of preferential basic helix loop helix genes; for detection of insectcide tolerant genes
12/04/2001US6326164 Contacting pyruvate and optionally, glyceraldehyde 3-phosphate, with polypeptide and determining the concentration of pyruvate and/or glyceradehyde 3-phosphate remaining
12/04/2001US6326163 Method for the direct diagnostic detection of genetically caused pathogenic point mutations
12/04/2001US6326162 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
12/04/2001US6326161 Rapid motor for cancer diagnosis
12/04/2001US6326153 Polynucleotide sequencing
12/04/2001US6326152 Exposing nadh dehydrogenase-expressing cells to test compound; measuring expression or enzymatic activity of nadh dehydrogenase in cells; selecting compound that down-regulates nadh dehydrogenase expression or activity
12/04/2001US6326151 Screening methods to identify agents that selectively inhibit hepatitis C virus replication
12/04/2001US6326150 Yeast interaction trap assay
12/04/2001US6326148 Detection of copy number changes in colon cancer
12/04/2001US6326146 Diagnosing humans with traumatic brain injury; obtain sample of brain tissue, detect destroyed cells in sample, monitor ribonucleic acids, compare to healthy humans
12/04/2001US6326145 Methods for detecting target nucleic acid sequences
12/04/2001US6326143 Elongating a primer molecule comprising a nucleobase sequence b' by using one or more nucleotide(s) and a target nucleic acid that acts as template for elongation of primer, product formed is capable of acting as template for elongation
12/04/2001US6326142 Measuring binding of polynucleotide to protein; label nucleotide sequences, measure polarization of fluorescent emission, incubate nucleotide sequence with protein, measure polarization and compare, detect complex formation
12/04/2001US6326141 Detecting pancreatic defect; evaluate humans for preferential gene expression, compare to healty human, amplified expression from preferential gene indicates pancreatic defect
12/04/2001US6326139 Screening for preferential genetic disorder; obtain blood, analyze serum for preferential enyzme levels before and after exposure to modulator, screen nucleotide sequences for preferential alleles and evaluate for geneic disorder
12/04/2001US6326137 Nucleotide sequences coding microorganism protein; for use in screening viricides; for prevention of viral infection
12/04/2001US6326136 Nucleic acid hybridization probes and immunological probes useful as research and diagnostic tools
12/04/2001US6326008 Toxoplasma gondii antigens, the preparation thereof and the use thereof
12/04/2001US6325973 Methods and apparatus for improved luminescence assays
12/04/2001US6325904 Nanoelectrode arrays
12/04/2001CA2278883C Very large scale immobilized peptide synthesis
12/04/2001CA2203295C High efficiency method for isolating target substances using a multisample separation device
12/04/2001CA2064906C Quantitation of nucleic acids using the polymerase chain reaction
12/01/2001CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof
11/2001
11/30/2001CA2728478A1 System and method for analyzing antibiotic susceptibility of biological samples
11/30/2001CA2347249A1 Mutant plk protein and gene encoding the same
11/29/2001WO2001090758A2 Diagnosis of alzheimer's disease ldl receptor protein-1
11/29/2001WO2001090757A1 Alzheimer's disease assay
11/29/2001WO2001090752A1 Method for producing an electrode coated with biomolecules
11/29/2001WO2001090746A1 Methods and computer software products for transcriptional annotation
11/29/2001WO2001090745A2 Determination of naaladase inhibitors
11/29/2001WO2001090421A2 Method of detecting inflammatory lung disorders
11/29/2001WO2001090420A1 Drug-oligonucleotides chimeric molecules
11/29/2001WO2001090419A2 Methods for genetic analysis of dna to detect sequence variances
11/29/2001WO2001090418A1 Rapid haplotyping by single molecule detection
11/29/2001WO2001090417A2 Materials and methods for detection of nucleic acids
11/29/2001WO2001090416A2 Methods and compositions for preparation of a polynucleotide array
11/29/2001WO2001090415A2 Method of producing a dna library using positional amplification
11/29/2001WO2001090414A1 In vitro evolution of nucleic acids and encoded polypeptide
11/29/2001WO2001090413A2 Method and markers for prognosticating efficacy of anticancer agents
11/29/2001WO2001090412A1 Methods and compositions for the diagnosis of schizophrenia
11/29/2001WO2001090411A1 Methods and compositions for the diagnosis of schizophrenia
11/29/2001WO2001090410A1 Nonradioactive rna analysis method and nonradioactive rna analysis kit
11/29/2001WO2001090409A1 Cancer diagnosis method
11/29/2001WO2001090408A2 Method for detecting and characterising activity of proteins involved in lesion and dna repair
11/29/2001WO2001090407A1 Quantitative measurement of molecular quantities in complex mixtures
11/29/2001WO2001090406A2 Compositions and methods for nucleic acid or polypeptide analyses
11/29/2001WO2001090405A1 Shared primer pcr combined with hybridisation for the detection of bordetella pertussis and b parapertussis
11/29/2001WO2001090404A1 Drug screening systems and assays
11/29/2001WO2001090403A1 Method and reagent kit for determining activity of 5'-nucleotidase
11/29/2001WO2001090402A1 New method and device
11/29/2001WO2001090401A2 Yeast strains to identify specific inhibitors of polo kinases
11/29/2001WO2001090400A2 Methods for monitoring production of gene products and uses thereof
11/29/2001WO2001090399A2 Detection of mutations and polymorphisms in nucleic acids
11/29/2001WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001WO2001090360A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001WO2001090359A2 G-protein coupled receptors
11/29/2001WO2001090354A1 Treatment of cancer and neurological diseases
11/29/2001WO2001090353A1 A process for determining the tumoricidal potential of a sample by the use of a nucleic acid which is downregulated in human tumor cells
11/29/2001WO2001090347A1 Antiviral antisense therapy
11/29/2001WO2001090341A1 Antisense modulation of pten expression
11/29/2001WO2001090337A2 Detection of rna
11/29/2001WO2001090334A2 Drug metabolizing enzymes
11/29/2001WO2001090330A2 AMINOACYL tRNA SYNTHETASES
11/29/2001WO2001090328A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/29/2001WO2001090313A2 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS
11/29/2001WO2001090312A1 Ammonia-oxidizing bacteria
11/29/2001WO2001090308A2 Method of determining thiopurine methyltransferase activity
11/29/2001WO2001090306A2 Compositions and methods for modulating tumor specific expression
11/29/2001WO2001090304A2 Nucleic acids, proteins, and antibodies
11/29/2001WO2001090189A2 G-protein coupled receptor org3.
11/29/2001WO2001090188A2 Receptor-based interaction trap
11/29/2001WO2001090185A2 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
11/29/2001WO2001090161A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
11/29/2001WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001WO2001090153A2 Reagents for cell selection and methods of use
11/29/2001WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001WO2001090151A2 Human receptor proteins; related reagents and methods